Mehrdad Hefazi T Cell Engineering Mayo Clinic Biography Publications Institution JoVE Articles Mehrdad Hefazi has not added a biography. If you are Mehrdad Hefazi and would like to personalize this page please email our Author Liaison for assistance. Publications Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma Blood. Jan, 2022 | Pubmed ID: 35090171 A Novel Iowa-Mayo Validated Composite Risk Assessment Tool for Allogeneic Stem Cell Transplantation Survival Outcome Prediction Blood Cancer Journal. 11, 2021 | Pubmed ID: 34802042 Emerging Approaches to Improve Allogeneic Hematopoietic Cell Transplantation Outcomes for Non-malignant Diseases Blood. Oct, 2021 | Pubmed ID: 34614174 Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges International Journal of Molecular Sciences. Sep, 2021 | Pubmed ID: 34575843 Ruxolitinib Resistance or Intolerance in Steroid-refractory Acute Graft-versus-host Disease - a Real-world Outcomes Analysis British Journal of Haematology. 11, 2021 | Pubmed ID: 34254289 Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity Cancer Immunology Research. 09, 2021 | Pubmed ID: 34244299 Multi-institutional Study Evaluating Clinical Outcome with Allogeneic Hematopoietic Stem Cell Transplantation After Blinatumomab in Patients with B-cell Acute Lymphoblastic Leukemia: Real-world Data Bone Marrow Transplantation. 08, 2021 | Pubmed ID: 33824440 Resistance to CART Cell Therapy: Lessons Learned from the Treatment of Hematological Malignancies Leukemia & Lymphoma. 09, 2021 | Pubmed ID: 33682608 Leukemic Extracellular Vesicles Induce Chimeric Antigen Receptor T cell Dysfunction in Chronic Lymphocytic Leukemia Molecular Therapy : the Journal of the American Society of Gene Therapy. 04, 2021 | Pubmed ID: 33388419 Sequencing of Novel Agents in Relapsed/refractory B-cell Acute Lymphoblastic Leukemia: Blinatumomab and Inotuzumab Ozogamicin May Have Comparable Efficacy As First or Second Novel Agent Therapy in Relapsed/refractory Acute Lymphoblastic Leukemia Cancer. 04, 2021 | Pubmed ID: 33259056 Cardiovascular Outcomes in Patients Receiving Myeloablative Vs. Reduced Intensity Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Bone Marrow Transplantation. 02, 2021 | Pubmed ID: 32772045 Bone Marrow Dendritic Cell Aggregates Associate with Systemic Immune Dysregulation in Chronic Myelomonocytic Leukemia Blood Advances. 11, 2020 | Pubmed ID: 33152058 Real-world Outcomes of Adult B-cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab Blood Advances. 05, 2020 | Pubmed ID: 32453836 Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin Clinical Lymphoma, Myeloma & Leukemia. 08, 2020 | Pubmed ID: 32291234 Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 07, 2019 | Pubmed ID: 31170029 Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. 06, 2019 | Pubmed ID: 30772513 GM-CSF Inhibition Reduces Cytokine Release Syndrome and Neuroinflammation but Enhances CAR-T Cell Function in Xenografts Blood. Feb, 2019 | Pubmed ID: 30463995 Recent Advances in the Biology and Treatment of B-cell Acute Lymphoblastic Leukemia Blood and Lymphatic Cancer : Targets and Therapy. 2018 | Pubmed ID: 31360093 The Association of De Novo Anti-HLA-DPB1 Donor-specific Antibody Formation and Primary Graft Failure After Allogeneic Hematopoietic Cell Transplantation Human Immunology. Dec, 2018 | Pubmed ID: 30142360 Non-internal Tandem Duplication (ITD), Non-tyrosine Kinase Domain (TKD) FLT3 Mutations in Myeloid Malignancies: A Brief Report of 10 Patients Leukemia Research. 09, 2018 | Pubmed ID: 30055376 Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia Current Hematologic Malignancy Reports. 08, 2018 | Pubmed ID: 29948644 Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome Without Significantly Impacting Measured Pulmonary Functions Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Sep, 2018 | Pubmed ID: 29679771 Thyroid Dysfunction in Adult Hematopoietic Cell Transplant Survivors: Risks and Outcomes Bone Marrow Transplantation. 08, 2018 | Pubmed ID: 29410547 Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series Mayo Clinic Proceedings. 11, 2017 | Pubmed ID: 29101931 Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Sep, 2017 | Pubmed ID: 28495641 Vancomycin-resistant Enterococcus Colonization and Bloodstream Infection: Prevalence, Risk Factors, and the Impact on Early Outcomes After Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia Transplant Infectious Disease : an Official Journal of the Transplantation Society. Dec, 2016 | Pubmed ID: 27642723 Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. 08, 2016 | Pubmed ID: 27164061 ABO Blood Group Incompatibility As an Adverse Risk Factor for Outcomes in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia Undergoing HLA-matched Peripheral Blood Hematopoietic Cell Transplantation After Reduced-intensity Conditioning Transfusion. Feb, 2016 | Pubmed ID: 26446051 Prognostic Impact of Combined NPM1+/FLT3- Genotype in Patients with Acute Myeloid Leukemia with Intermediate Risk Cytogenetics Stratified by Age and Treatment Modalities Leukemia Research. Sep, 2015 | Pubmed ID: 26410460 Imaging dinamico di cellule T del recettore dell'antigene chimerico con [18F] tomografia ad emissione di positroni tetrafluoroborato/tomografia computerizzata Reona Sakemura1,2, Michelle J. Cox1,2, Aditya Bansal3, Claudia Manriquez Roman1,2,4,5, Mehrdad Hefazi1,2, Cynthia J. Vernon3, Dianna L. Glynn3, Mukesh K. Pandey3, Timothy R. DeGrado3, Elizabeth L. Siegler1,2, Saad S. Kenderian1,2,5,6 1T Cell Engineering, Mayo Clinic, 2Division of Hematology, Mayo Clinic, 3Department of Radiology, Mayo Clinic, 4Regenerative Sciences PhD, Mayo Clinic, 5Department of Molecular Medicine, Mayo Clinic, 6Department of Immunology, Mayo Clinic JoVE 62334 Cancer Research
Imaging dinamico di cellule T del recettore dell'antigene chimerico con [18F] tomografia ad emissione di positroni tetrafluoroborato/tomografia computerizzata Reona Sakemura1,2, Michelle J. Cox1,2, Aditya Bansal3, Claudia Manriquez Roman1,2,4,5, Mehrdad Hefazi1,2, Cynthia J. Vernon3, Dianna L. Glynn3, Mukesh K. Pandey3, Timothy R. DeGrado3, Elizabeth L. Siegler1,2, Saad S. Kenderian1,2,5,6 1T Cell Engineering, Mayo Clinic, 2Division of Hematology, Mayo Clinic, 3Department of Radiology, Mayo Clinic, 4Regenerative Sciences PhD, Mayo Clinic, 5Department of Molecular Medicine, Mayo Clinic, 6Department of Immunology, Mayo Clinic JoVE 62334 Cancer Research
